Scintigraphic predictors of response to treatment in Sjogren's syndrome.

被引：0
|
作者：
Vivino, FB
Hermann, GA
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2047
引用
收藏
页码：S408 / S408
页数：1
相关论文
共 50 条
  • [21] Prognosis factors in primary Sjogren's syndrome.
    Fauchais, AHL
    Hatron, PY
    Pasturel, U
    Lambert, M
    Queyrel, V
    Hebbar, M
    Hachulla, E
    Devulder, B
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S305 - S305
  • [22] Antiovarian antibodies in primary Sjogren's syndrome.
    Andonopoulos, AP
    Euthymiopoulou, K
    Ravazoula, P
    Daoussis, D
    Liossis, SN
    Aletras, A
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S377 - S378
  • [23] Role of enteroviruses in the etiology of Sjogren's syndrome.
    Triantafyllopoulou, A
    Tapinos, N
    Liakos, DA
    Moutsopoulos, HM
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S258 - S258
  • [24] Cytotoxic granules and apoptosis in Sjogren's syndrome.
    Saito, K
    Takeuchi, T
    Abe, T
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1164 - 1164
  • [25] Celiac disease and primary Sjogren's syndrome.
    Iltanen, S
    Collin, P
    Korpela, M
    Holm, K
    Partanen, J
    Polvi, A
    Maki, M
    GASTROENTEROLOGY, 1997, 112 (04) : A371 - A371
  • [26] Salivary electrophoresis in the diagnosis of Sjogren's syndrome.
    Yaltirik, M
    Aydil, BA
    Koçak, H
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : B267 - B267
  • [27] Neurological manifestations of primary Sjogren's syndrome.
    Lafitte, C
    REVUE NEUROLOGIQUE, 1998, 154 (10) : 658 - 673
  • [28] Oral microflora in patients with Sjogren's syndrome.
    Almstahl, A
    Kroneld, U
    Tarkowski, A
    Wikstrom, M
    JOURNAL OF DENTAL RESEARCH, 1997, 76 : 3134 - 3134
  • [29] Multiple TRIM proteins are targets of autoimmune response in lupus and Sjogren's syndrome.
    Rybakowska, Paulina
    Wolska, Nina
    Klopocki, Arkadiusz
    Sivils, Kathy
    James, Judith
    Bagavant, Harini
    Deshmukh, Umesh
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [30] Epratuzumab (anti-CD22) for the treatment of primary \SjoGren's syndrome.
    Steinfeld, SD
    Pradier, O
    Song, I
    Burmester, GR
    Wegener, WA
    Xu, L
    Horak, ID
    Goldenberg, DM
    Tant, L
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S277 - S277
12345